Cargando…

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?

This single-center study aimed to retrospectively evaluate the survival outcomes of patients with FIGO stage I clear cell and serous uterine carcinoma according to the type of adjuvant treatment received. The data were collected between 2003 and 2020 and only patients with stage I clear cell or sero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lefebvre, Manon, Duchatelet, Mathilde, El Hajj, Houssein, De Courrèges, Antoine, Wallet, Jennifer, Bellier, Charlotte, Le Tinier, Florence, Le Deley, Marie Cécile, Martinez Gomez, Carlos, Leblanc, Eric, Narducci, Fabrice, Hudry, Delphine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858549/ https://www.ncbi.nlm.nih.gov/pubmed/36661739 http://dx.doi.org/10.3390/curroncol30010090

Ejemplares similares

Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne’s Thread in Early Cervical Cancer Treatment?
por: Serouart, Benjamin, et al.
Publicado: (2023)

Conservative treatment of glassy cell cervical cancer: A case report
por: El Hajj, Houssein, et al.
Publicado: (2022)

A New Paradigm in Managing Advanced Ovarian Cancer: Differentiating Patients Requiring Neoadjuvant Treatment from Primary Cytoreduction
por: Kraus, Francois, et al.
Publicado: (2021)

Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints
por: Hudry, Delphine, et al.
Publicado: (2022)

Prognostic impact of tumor size reduction assessed by magnetic resonance imaging after radiochemotherapy in patients with locally advanced cervical cancer
por: Cordoba, Abel, et al.
Publicado: (2022)

Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgery(☆)
por: El Hajj, H., et al.
Publicado: (2021)

Intracystic endometrioid borderline tumor
por: El Hajj, Houssein, et al.
Publicado: (2023)

Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study
por: Leblanc, Eric, et al.
Publicado: (2023)

IMRT in the treatment of locally advanced or inoperable NSCLC in the pre-durvalumab era: clinical outcomes and pattern of relapses, experience from the Oscar Lambret Center
por: Le Roy, Thomas, et al.
Publicado: (2023)

Combined modality therapy in the adjuvant treatment of uterine serous carcinoma
por: Block, Alec M., et al.
Publicado: (2016)

Evaluation of adjuvant therapy in women with uterine papillary serous cancer
por: Al Husaini, Hamed, et al.
Publicado: (2012)

Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta‐analysis of survival
por: Raffone, Antonio, et al.
Publicado: (2021)

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers
por: Hamilton, C A, et al.
Publicado: (2006)

An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers
por: Vogel, Tilley Jenkins, et al.
Publicado: (2015)

Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer
por: Jeans, Elizabeth B, et al.
Publicado: (2021)

The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry
por: Mattes, Malcolm D., et al.
Publicado: (2015)

Pathogenesis and Clinical Management of Uterine Serous Carcinoma
por: Zhang, Li, et al.
Publicado: (2020)

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
por: Santin, A D, et al.
Publicado: (2005)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
por: Shimizu, Maho, et al.
Publicado: (2021)

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
por: McNamara, Blair, et al.
Publicado: (2023)

Evaluation of an ultrasound bladder scanner in supine and standing position
por: Crop, Frederik, et al.
Publicado: (2021)

Survival of women with clear cell and papillary serous endometrial cancer after adjuvant radiotherapy
por: Foerster, Robert, et al.
Publicado: (2014)

Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy
por: Tate, Keisei, et al.
Publicado: (2018)

The Impact of Adjuvant Management Strategies on Outcomes in Women With Early Stage Uterine Serous Carcinoma
por: Cook, Andrew, et al.
Publicado: (2021)

Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011)

Papillary Serous Carcinoma of the Uterine Cervix with Lung Metastasis
por: Khan, Maliha, et al.
Publicado: (2014)

Improved survival of patients with hypermutation in uterine serous carcinoma
por: Santin, Alessandro D., et al.
Publicado: (2015)

Adrenal Metastasis from Uterine Papillary Serous Carcinoma
por: Lubana, Sandeep Singh, et al.
Publicado: (2016)

The role of omentectomy in the surgical treatment of uterine serous carcinoma
por: Chen, Ming, et al.
Publicado: (2019)

Stereotactic body radiotherapy for intramedullary metastases: a retrospective series at the Oscar Lambret center and a systematic review
por: Tonneau, Marion, et al.
Publicado: (2021)

Uterine Serous Adenocarcinoma in an Elderly Postmenopausal Woman: Clinically Misdiagnosed as Uterine Cervix Cancer
por: Hong, Jeong-A, et al.
Publicado: (2015)

A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system
por: Kim, Ha-Jeong, et al.
Publicado: (2013)

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling
por: Santin, A D, et al.
Publicado: (2004)

Serous carcinoma of the uterine cervix: Clinicopathological features differing from serous carcinomas of other female organs
por: Kitade, Shoko, et al.
Publicado: (2019)

Combined Adjuvant Chemotherapy and Radiation Therapy Improves Disease-Free Survival for Uterine Serous Cancer
por: Arden, Jessica D., et al.
Publicado: (2020)

Metastatic papillary serous uterine cancer presenting as a rash
por: Chang, Eric S., et al.
Publicado: (2016)

Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel
por: Seino, Manabu, et al.
Publicado: (2018)

BET inhibitors: Betting on improved outcomes in uterine serous carcinoma
por: Zeybek, Burak, et al.
Publicado: (2018)

Superior vena cava syndrome associated with uterine serous carcinoma
por: Laibangyang, Anya, et al.
Publicado: (2020)

Impact of positive cytology in uterine serous carcinoma: A reassessment
por: Corey, Logan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u8im9kcfto4cog2h32t8h3t4u6